Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324333879> ?p ?o ?g. }
- W4324333879 endingPage "104613" @default.
- W4324333879 startingPage "104613" @default.
- W4324333879 abstract "Epstein-Barr virus (EBV) is a member of the lymphotropic virus family and is highly correlated with some human malignant tumors. It has been reported that envelope glycoprotein 110 (gp110) plays an essential role in viral fusion, DNA replication, and nucleocapsid assembly of EBV. However, it has not been established whether gp110 is involved in regulating the host's innate immunity. In this study, we found that gp110 inhibits tumor necrosis factor α-mediated NF- κB promoter activity and the downstream production of NF- κB-regulated cytokines under physiological conditions. Using dual-luciferase reporter assays, we showed that gp110 might impede the NF-κB promoter activation downstream of NF-κB transactivational subunit p65. Subsequently, we used coimmunoprecipitation assays to demonstrate that gp110 interacts with p65 during EBV lytic infection, and that the C-terminal cytoplasmic region of gp110 is the key interaction domain with p65. Furthermore, we determined that gp110 can bind to the N-terminal Rel homologous and C-terminal domains of p65. Alternatively, gp110 might not disturb the association of p65 with nontransactivational subunit p50, but we showed it restrains activational phosphorylation (at Ser536) and nuclear translocation of p65, which we also found to be executed by the C-terminal cytoplasmic region of gp110. Altogether, these data suggest that the surface protein gp110 may be a vital component for EBV to antagonize the host's innate immune response, which is also helpful for revealing the infectivity and pathogenesis of EBV." @default.
- W4324333879 created "2023-03-16" @default.
- W4324333879 creator A5005764524 @default.
- W4324333879 creator A5006901857 @default.
- W4324333879 creator A5007260582 @default.
- W4324333879 creator A5007433869 @default.
- W4324333879 creator A5008296079 @default.
- W4324333879 creator A5011986143 @default.
- W4324333879 creator A5012087277 @default.
- W4324333879 creator A5012813535 @default.
- W4324333879 creator A5014533727 @default.
- W4324333879 creator A5019975620 @default.
- W4324333879 creator A5022677018 @default.
- W4324333879 creator A5023101702 @default.
- W4324333879 creator A5033551430 @default.
- W4324333879 creator A5048727442 @default.
- W4324333879 creator A5054149015 @default.
- W4324333879 creator A5054713934 @default.
- W4324333879 creator A5058215005 @default.
- W4324333879 creator A5063396070 @default.
- W4324333879 creator A5070524866 @default.
- W4324333879 creator A5082061841 @default.
- W4324333879 creator A5082472366 @default.
- W4324333879 creator A5086861827 @default.
- W4324333879 creator A5087570990 @default.
- W4324333879 creator A5088985864 @default.
- W4324333879 date "2023-05-01" @default.
- W4324333879 modified "2023-10-14" @default.
- W4324333879 title "Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65" @default.
- W4324333879 cites W1529003390 @default.
- W4324333879 cites W1577722824 @default.
- W4324333879 cites W1605908963 @default.
- W4324333879 cites W1661741137 @default.
- W4324333879 cites W1793190047 @default.
- W4324333879 cites W1892689796 @default.
- W4324333879 cites W1964392254 @default.
- W4324333879 cites W1965003906 @default.
- W4324333879 cites W1973640489 @default.
- W4324333879 cites W1983065398 @default.
- W4324333879 cites W1985880387 @default.
- W4324333879 cites W1988233041 @default.
- W4324333879 cites W1991600236 @default.
- W4324333879 cites W1996339554 @default.
- W4324333879 cites W1996683613 @default.
- W4324333879 cites W1997901905 @default.
- W4324333879 cites W1998742383 @default.
- W4324333879 cites W1998812648 @default.
- W4324333879 cites W2003045938 @default.
- W4324333879 cites W2003879839 @default.
- W4324333879 cites W2004005441 @default.
- W4324333879 cites W2015614892 @default.
- W4324333879 cites W2016119598 @default.
- W4324333879 cites W2019158040 @default.
- W4324333879 cites W2041971745 @default.
- W4324333879 cites W2055617460 @default.
- W4324333879 cites W2061267724 @default.
- W4324333879 cites W2070085780 @default.
- W4324333879 cites W2072977927 @default.
- W4324333879 cites W2079635715 @default.
- W4324333879 cites W2085067953 @default.
- W4324333879 cites W2086086480 @default.
- W4324333879 cites W2094905609 @default.
- W4324333879 cites W2108233169 @default.
- W4324333879 cites W2112956340 @default.
- W4324333879 cites W2114890741 @default.
- W4324333879 cites W2115370610 @default.
- W4324333879 cites W2115403417 @default.
- W4324333879 cites W2115616959 @default.
- W4324333879 cites W2116752222 @default.
- W4324333879 cites W2122044177 @default.
- W4324333879 cites W2124950819 @default.
- W4324333879 cites W2134887638 @default.
- W4324333879 cites W2141068744 @default.
- W4324333879 cites W2142081586 @default.
- W4324333879 cites W2142404794 @default.
- W4324333879 cites W2144454093 @default.
- W4324333879 cites W2156805103 @default.
- W4324333879 cites W2161746474 @default.
- W4324333879 cites W2164895102 @default.
- W4324333879 cites W2167262402 @default.
- W4324333879 cites W2170440338 @default.
- W4324333879 cites W2192123449 @default.
- W4324333879 cites W2260923959 @default.
- W4324333879 cites W2274992591 @default.
- W4324333879 cites W2316009979 @default.
- W4324333879 cites W2564952670 @default.
- W4324333879 cites W2569333152 @default.
- W4324333879 cites W2624487449 @default.
- W4324333879 cites W2738451851 @default.
- W4324333879 cites W2801294878 @default.
- W4324333879 cites W2945865620 @default.
- W4324333879 cites W2951072147 @default.
- W4324333879 cites W2963299042 @default.
- W4324333879 cites W2971425078 @default.
- W4324333879 cites W2996445090 @default.
- W4324333879 cites W3004592268 @default.
- W4324333879 cites W3015074995 @default.
- W4324333879 cites W3025861112 @default.